Clark Capital Management Group, Inc. Sanofi Transaction History

Clark Capital Management Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $973,195 - $1.05 Million	19,101 Added 3.22%	612,979 $32.9 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $4.28 Million - $4.85 Million	-84,754 Reduced 12.49%	593,878 $32 Million
Q1 2023 May 15, 2023	SELL	$45.86 - $54.45 $4.16 Million - $4.93 Million	-90,612 Reduced 11.78%	678,632 $36.9 Million
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $7.64 Million - $9.55 Million	-196,706 Reduced 20.36%	769,244 $37.3 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $1.22 Million - $3.29 Million	32,705 Added 3.5%	965,950 $36.7 Million
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $2.03 Million - $2.38 Million	41,437 Added 4.65%	933,245 $46.7 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $1.81 Million - $2.01 Million	37,424 Added 4.38%	891,808 $45.8 Million
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $10.6 Million - $11.8 Million	226,027 Added 35.97%	854,384 $42.8 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $30.1 Million - $33.4 Million	628,357 New	628,357 $30.3 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $23.9 Million - $25.9 Million	-482,149 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $20.7 Million - $25.3 Million	482,149 New	482,149 $24.6 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $1.89 Million - $2.23 Million	-44,100 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $2.07 Million - $2.22 Million	44,100	44,100 $2.2 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Clark Capital Management Group, Inc. with notifications on news.